United KingdomA study warns that long-term use of the erectile dysfunction drug tadalafil may increase the risk of glaucoma, a leading cause of blindness worldwide. Researchers from Taiwan analyzed data from 73,854 men aged 40 and older with lower urinary tract symptoms, comparing those using tadalafil or other PDE5 inhibitors with those on alternative medications. The study found that men on tadalafil were 22% more likely to develop glaucoma and 32% more likely to develop ocular hypertension after five years. They were also 33% more likely to develop primary open-angle glaucoma, the most common type. However, since the study was observational, no definitive causal link between tadalafil and glaucoma was established. Experts emphasize the importance of monitoring eye health for individuals on long-term tadalafil therapy, especially those with pre-existing glaucoma or a family history of the condition.
Bias read (Center): The article presents a scientific study without overt ideological framing. It reports on medical research findings without promoting a specific political agenda. While the issue of drug safety has broader implications for public health policy, the article does not take a partisan stance or advocate,
